StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) income statement

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.11−0.09 (-2.81%)

Close on Nov 18, 2026Market cap $217.99MP/E –Yield 0.00%

Bicycle Therapeutics PLC income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-189.4%
Net margin
-169.8%
Return on equity, FY2025
-31.2%

Financial strength

Current ratio
12.09
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1057.0%

Valuation

P/E ratio
–
Price to sales
2.61
Price to book
0.43
Dividend yield
0.00%

See a number that looks wrong?